Abstract:Across published in vivo studies related to 20 FDA-approved cancer therapies, drugmodel pairs which achieved a high DELVE score showed greater than or equal to 90% tumor growth inhibition in vivo 78% of the time. Drug-model pairs with low DELVE scores showed less than or equal to 60% tumor growth inhibition in vivo 77% of the time. Across 71 FDA-approved drugs, using chemical structure alone, the platform was able to predict at least one approved solid tumor indication 84% of the time. Random chance indication… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.